The proportion of patients achieving a prostate-specific antigen nadir less than or equal to 0.2 ng/ml was exactly the same for patients treated with transdermal estradiol patches and those treated ...

Based on phase 3 trial findings, investigators conclude that transdermal estradiol should be a standard of care ADT option for patients with nonmetastatic prostate cancer. Transdermal estradiol (tE2) ...

Bethesda, MD - In a head-to-head crossover comparison, oral estrogen therapy (ET) was associated with a sustained increase in the inflammatory marker C-reactive protein (CRP) among postmenopausal ...

DALLAS – April 16, 2003 – Administering estrogen replacement therapy via a skin patch rather than a pill minimizes a cardiovascular risk factor in postmenopausal women, according to researchers at UT ...

PORTLAND, Ore. -- A small adhesive estrogen patch worn by men being treated for advanced prostate cancer lowers cholesterol, according to a new study conducted by Oregon Health & Science University ...

The optimal treatment for menopausal hot flashes is estrogen therapy. 4 Estrogen replacement results in a markedly greater reduction in the frequency and severity of hot flashes than placebo, as ...

Please provide your email address to receive an email when new articles are posted on . As researchers continue to assess complications of COVID-19, one striking difference has become clear — men who ...

There is a particular type of adhesive patch that many people have used before. It is called a transdermal patch. Unlike a Band-Aid, it’s specific uses to deliver medication that is saturated on the ...

Most estrogen patch side effects (like bloating, nausea, and breast tenderness) are mild, temporary, and improve as the body adjusts. Less common side effects may affect comfort or quality of life but ...